These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34702761)

  • 21. Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
    Altuntas CZ; Daneshgari F; Liu G; Fabiyi A; Kavran M; Johnson JM; Gulen MF; Jaini R; Li X; Frenkl TL; Tuohy VK
    J Neuroimmunol; 2008 Oct; 203(1):58-63. PubMed ID: 18703233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation site influences virulence phenotype of serotype 14 Streptococcus pneumoniae strains belonging to multilocus sequence type 15.
    Amin Z; Harvey RM; Wang H; Hughes CE; Paton AW; Paton JC; Trappetti C
    Infect Immun; 2015 Dec; 83(12):4781-90. PubMed ID: 26416904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Hasseldam H; Hansen CS; Johansen FF
    Parasite Immunol; 2013; 35(3-4):103-108. PubMed ID: 23227936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis.
    Ghareghani M; Scavo L; Arnoult D; Zibara K; Farhadi N
    Fundam Clin Pharmacol; 2018 Apr; 32(2):181-187. PubMed ID: 29193274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis.
    Ghareghani M; Zibara K; Sadeghi H; Farhadi N
    Cell Mol Neurobiol; 2018 Jul; 38(5):1145-1151. PubMed ID: 29497878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels.
    Lee-Chang C; Lefranc D; Salleron J; Faveeuw C; Allet C; Vermersch P; Oxombre B; Prin L
    Immunol Lett; 2011 Mar; 135(1-2):108-17. PubMed ID: 20946917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.
    Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A
    Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Streptococcus pneumoniae septicemia. Analysis of 40 cases].
    Noriega LM; González P; Canals C; Michaud P
    Rev Med Chil; 1994 Dec; 122(12):1385-92. PubMed ID: 7659913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes.
    Faber H; Kurtoic D; Krishnamoorthy G; Weber P; Pütz B; Müller-Myhsok B; Weber F; Andlauer TFM
    Front Immunol; 2020; 11():2165. PubMed ID: 33072080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased susceptibility to Candida infection following cecal ligation and puncture.
    Davis CG; Chang K; Osborne D; Walton AH; Dunne WM; Muenzer JT
    Biochem Biophys Res Commun; 2011 Oct; 414(1):37-43. PubMed ID: 21939638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Ludwig MD; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Tauber SC; Nau R; Gerber J
    Arch Physiol Biochem; 2007 Jun; 113(3):124-30. PubMed ID: 17922308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program.
    Miyazaki H; Shibuya R; Midorikawa N; Chang B; Ohnishi M; Matsumoto T
    J Infect Chemother; 2017 Apr; 23(4):234-240. PubMed ID: 28161295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.
    Sato F; Martinez NE; Shahid M; Rose JW; Carlson NG; Tsunoda I
    Am J Pathol; 2013 Nov; 183(5):1390-1396. PubMed ID: 24091251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.
    Gold R; Linington C; Lassmann H
    Brain; 2006 Aug; 129(Pt 8):1953-71. PubMed ID: 16632554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7.
    Regev-Yochay G; Rahav G; Strahilevitz J; Bishara J; Katzir M; Chowers M; Finkelstein R; Chazan B; Zimhony O; Dagan R;
    Vaccine; 2013 May; 31(19):2387-94. PubMed ID: 23518404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE).
    Bolton C; Smith PA
    Ageing Res Rev; 2018 Jan; 41():64-81. PubMed ID: 29101043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study.
    Theilacker C; Ludewig K; Serr A; Schimpf J; Held J; Bögelein M; Bahr V; Rusch S; Pohl A; Kogelmann K; Frieseke S; Bogdanski R; Brunkhorst FM; Kern WV
    Clin Infect Dis; 2016 Apr; 62(7):871-878. PubMed ID: 26703862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity.
    Ruan J; Schlüter D; Wang X
    J Neuroinflammation; 2020 Apr; 17(1):102. PubMed ID: 32248814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis.
    Ugarte-Berzal E; Berghmans N; Boon L; Martens E; Vandooren J; Cauwe B; Thijs G; Proost P; Van Damme J; Opdenakker G
    PLoS One; 2018; 13(10):e0197944. PubMed ID: 30273366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.